Antecedentes maternos prenatales y riesgo de complicaciones neonatales en productos de término de bajo peso para edad gestacional / Maternal prenatal history and neonatal risk complications for low-weight for gestacional age term newborns

Resumen Introducción: El bajo peso neonatal (< 2.5 kg o < percentil 10) se atribuye a causas constitucionales (pequeño para la edad gestacional [PEG]) o a la restricción en el crecimiento intrauterino (RCIU), con riesgos posnatales diferentes. En ausencia de una valoración fetal-placentaria prenatal adecuada, resulta difícil establecerlo. El conocer los antecedentes maternos de enfermedades gestacionales (AMEG): hipertensión arterial (HTA), hipotiroidismo, Diabetes Mellitus (DM) gestacional y otra; pudiera orientar a la diferenciación y el manejo. El objetivo de este trabajo fue determinar si la presencia de AMEG se asocia a complicaciones neonatales en productos de bajo peso neonatal. Métodos: Se realizó un estudio de cohorte retrospectivo en un grupo de 349 recién nacidos vivos de término (≥ 37 semanas de edad gestacional [SEG]), PEG, en cunero fisiológico y agrupados según los AMEG. Se determinó la frecuencia de dificultad respiratoria (DR), hipoglucemia (HG) e hiperbilirrubinemia (HBr). Resultados: El 16.6% (58/349) presentó AMEG (58.6% HTA y 41.3% hipotiroidismo, solos o combinados). Los neonatos con AMEG fueron más limítrofes (37 SEG, 55.2% vs. 35.1%; p = 0.037). Los de 37 SEG con menor peso (diferencia de ≈100 g; p = 0.028), más riesgo de HG (13.6%; intervalo de confianza al 95% [IC 95%]: −4.08-31.2) pero menos DR (diferencia de −4.7%; IC 95%: −20.6-11.05). La HG en los de 39 SEG solo se presentó en neonatos sin AMEG (diferencia 12.7%; IC 95%: 3.9 a 31.5) igual que la HBr (tres casos). Conclusiones: Indagar sobre los AMEG en un producto PEG parece ser útil en la inferencia de RCIU. Sin embargo, es insuficiente, por lo que en conjunto con otras herramientas nos ayuda a estimar posibles complicaciones y acciones preventivas.

Abstract Background: Low-birth-weight (LWB < 2.5 kg or <10 percentile) could be caused by constitutional matters or by intrauterine growth restriction (IUGR), both with different neonatal complications. Without an adequate prenatal evaluation is hard to stablish those conditions. Knowing the maternal history for gestational diseases (MHGD) such as hypertension (HTA), hypothyroidism or diabetes, among others could help clarify that difference. The aim of this work was to determine if having a MHGD is associated to neonatal complications in newborns with LWB. Methods: Retrospective cohort study, which included 349 with LWB at term (≥ 37 weeks of gestation [WG]) grouped into those with or without MHGD at a hospital nursery. The frequency of respiratory distress, hypoglycemia, and hyperbilirubinemia was determined. Results: 16.6% (58/349) had MHGD (58.6% for HTA and 41.3% hypothyroidism alone or combined). The neonate with MHGD were more borderline term (37 WGA, 55.2% vs. 35.1%; p = 0.037), and had lower weight (difference of ≈100 g; p = 0.028), had more cases with hypoglycemia (13.6%; CI 95%: −4.08 to 31.2%) but developed less respiratory distress (RD) (difference of −4.7%; CI 95%: −20.6 to 11.05%). Hypoglycemia in 39 WGA was only seen among neonates without MHGD (difference 12.7%; CI95%: 3.9 to 31.5%) just as for the hyperbilirubinemia cases (three). Conclusions: Inquiring about the MHGD on LBW term babies could be useful in the inference of IUGR, although we need other tools so that altogether can help to predict possible complications and to plan preventive actions.

Transcutaneous bilirubin levels in healthy term and late preterm indian neonates.

Objective. To provide normative data for transcutaneous bilirubin (TcB) measurements in healthy term and late-preterm Indian neonates during first 72 h of age using a multiwavelength reflectance transcutaneous bilimeter. Methods. TcB measurements were performed in healthy neonates (gestation 35 wk), in a well-baby ward, using a multiwavelength transcutaneous bilimeter (BiliCheck®, SpectRx Inc, Norcross, GA). Age-specific percentiles values for each 6- h epoch starting at 0 h of age were calculated and an age-specific TcB nomogram was developed using different percentile values. Diagnostic ability of each percentile curve for prediction of hyperbilirubinemia, defined as requirement of phototherapy, was calculated. Results. We performed 925 TcB measurements on 625 healthy newborn infants (gestation: 35 to 41 wk; age: 0 to 72 h; mean birth weight: 2808±437 g). TcB increased in a linear manner with maximum rate of rise observed during first 24 h of age (50th percentile: 0.22 mg/dL/h). 50th percentile curve of age-specific TcB nomogram had high negative predictive value (99.8%) and acceptable positive predictive value (16.4%) for prediction of hyperbilirubinemia. Conclusion: We provided age-specific nomogram of TcB for first 72 h of age in healthy term and late-preterm Indian neonates. Percentile curves and rate of rise in TcB may help in identification of neonates at low-risk of development of hyperbilirubinemia facilitating their safer discharge from the hospital. Diagnostic utility of this nomogram for predicting hyperbilirubinemia needs to be tested in a separate validation cohort.

Subdiagnóstico de restricción de crecimiento fetal mediante la aplicación de las curvas de crecimiento intrauterino del Ministerio de Salud / Under diagnosis of fetal growth restriction by the new growth curves of the Chilean Ministry of Health

Background: Fetal growth restriction (FGR) is associated with increased risk of perinatal morbidity or death. Nationwide implementation of new fetal growth charts, requires a lower fetal weight for the diagnosis of FGR, compared to previous ones. This may lead to an under diagnosis of FGR in a large proportion of neonates. Aim: To compare the morbidity, mortality and anthropometry of neonates with FGR, diagnosed by MINSAL and Juez curves, with normal weight newborns in the same period (2000-2004). Material and methods: Revision of medical records of all births occurring in a maternity hospital between 2000 and 2004. The number of neonatal deaths, and the presence of hyperbilirubinemia, polyglobulia, hypoglycemia and hypothermia, were compared among children classified to be below percentile 10 of fetal growth according to both growth charts. Results: FGR was diagnosed in 4,4 percent (502/11.289) and 9 percent (1.029/11.289) of newborns by MINSAL and Juez curves respectively. Compared to normal weight controls, the 527 newborns without FGR according to MINSAL curves, but below percentile 10 of Juez curves, had an odds ratio (OR) for polyglobulina of 8.14 (95 percent confidence intervals (CI): 1.01-65.34), an OR for neonatal hypoglycemia of 5.10 (95 percent CI: 1.11-23.39) and an OR for a ponderal index below 10th percentile of 10.98 (95 percent CI: 6.84-17.64). Conclusions: Newborns without a diagnosis of FGR by MINSAL curves but below 10th percentile by Juez curves, have neonatal outcomes suggesting a true FGR. Juez curves should be maintained as a standard for the evaluation of fetal growth in our population.

Unusual clustering of diseases and manifestations in pediatric admissions of a tertiary care center.

BACKGROUND: Cluster investigations has been an important tool in investigations of diseases. While clustering of diseases or a manifestation in community can cause great public alarm, similar unexplained clustering in hospital admissions has baffled clinicians. Objectives: (a) To determine whether perceived unexplained clustering of diseases and manifestations among hospital admissions is real or significant. (b) To look for possible explanations of such clustering. DESIGN: One-year prospective observational and two-year retrospective study. MATERIAL AND METHODS: Cases admitted under pediatric and neonatal services (excluding rooming in babies) from September 2002 to August 2003 formed material for prospective and cases admitted for 2 years prior for retrospective study. Whenever an unexplained cluster of disease/manifestation was perceived, case definition was finalized and cases recorded. Retrospective cluster analysis was done for some significant unexplained clusters detected prospectively. These clusters case rate were analyzed in relation to age, sex, climatic conditions, etiology of case, etc. to detect any correlation. Pearson correlation coefficient, chi-square test, centroid method and Z test of proportion were used for statistical significance. RESULTS: Eight unexplained clusters were perceived in prospective study. 3 (hyperbilirubinemia in exchange range hypocalcemic seizures and vesicoureteric reflux) proved statistically not significant. 3 were small clusters of uncommon diseases / manifestations (biliary atresia, cardiomyopathy, and acral gangrene). Two large significant clusters, major non-traumatic bleeding manifestations (MNTBM) and acute renal failure (ARF) occurred to which retrospective study was extended. Tmax and Tmin (average maximum and minimum daily temperature) had statistically significant positive correlation with ARF (gamma = + 0.83, P <0.001 for Tmax and gamma =+ 0.56, P = 0.002 for Tmin) and negative correlation with MNTBM (gamma = - 0.34, P = 0.040 for Tmax and gamma = - 0.59, P <0.001 for Tmin). Barometric pressure has significant negative and positive correlation with MNTBM and ARF respectively (gamma =+ 0.57, P <0.001 for MNTBM and gamma = -0.45,P = 0.006 for ARF). The clusters also had significant positive correlations with female sex and age under 1 year (Z = 2.48, P <0.001,chi2=13.83, P<0.001 for sex and age of MNTBM and Z =3.11, P <0.001, chi2 =10.85, P <0.001 forage and sex of ARF cases respectively). Three small clusters and a small subgroup of MNTBM(subcutaneous nodules as manifestations of bleeding disorders) occurred predominantly under one year and different sexes were involved. CONCLUSIONS: Several significant unexplained clustering were noted among hospital admissions. There was significant correlation with climatic conditions, age and sex. Larger, longer and multicentric studies in different geographical areas are required to investigate more plausible but complex biological phenomenon and associations related to diseases or manifestations. Cluster awareness has diagnostic and management implications for clinician as it also helps in early recognition of disease outbreak and dissemination of information and hospital staff to be prepared to handle increased number of cases and its treatment.

Audiometria de tronco cerebral e hiperbilirrubinemia em neonatos de alto risco / Auditory test of the central nervous system and hyperbilirrubinemia in neonates

Os autores avaliaram pela BSER 30 neonatos portadores de hiperbilirrubinemia, oriundos da Disciplina de Perinatologia. A maioria dos sujeitos foram avaliados com menos de 2 semanas de vida (21/3); houve perdominância do sexo masculino em 60 (por cento) (18/30); a hiperbilirrubinemia variou de 9,0 mg/dl, com média de 17,5 mg/dl. As patologias mais frequentes associadas foram a hipoxemia perinatal (7/30) e a administraçäo de aminoglicosídeos (7/30). Dos 30 sujeitos analisados pela BSER 40 (por cento)(12/30) apresentaram respostas normais, 13,5 (por cento) (4/30) disacusia unilateral e 46,5 (por cento) (14/30) disacusia bilateral. Dos ouvidos avaliados, ocorreram 26,5 (por cento)(16/60) com alteraçöes sensoriais, 10 (por cento) (6/60) com alteraçöes neurais e 16,5 (por cento)(10/60) com BSER sem respostas. Quanto à intensidade da deficiência auditiva, aferida pelo limiar eletrofisiológico, 53 (por cento) (32/60) dos ouvidos apresentaram disacusia severa e/ou profunda (limiar acima de 71 dB NA). Em 6 neonatos foram feitas monitorizaçäo pela BSER pré e pós exsanguíneo-transfusäo. Destes, 2 pacientes apresentaram respostas normais nas 2 situaçöes; em 4 sujeitos portadores de disacusia severa/profunda bilateral apresentaram normalizaçäo das respostas à BSER após a exsanguíneo-transfusäo